| Dermatitis |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Atopic Dermatitis |
0 |
0.98 |
| Interleukin |
0 |
0.35 |
| Acne |
0 |
0.21 |
| Otolaryngology |
0 |
0.17 |
| Abdominal Pain |
0 |
0.15 |
| Upper Respiratory Tract Infection |
0 |
0.12 |
| Abdomen |
0 |
0.09 |
| Adverse Effects |
0 |
0.09 |
| Clinical Guidelines |
0 |
0.09 |
| Cytokines |
0 |
0.09 |
| Eczema |
0 |
0.09 |
| Lymphoproliferative Disorders |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Nasopharyngitis |
0 |
0.09 |
| Nausea |
0 |
0.09 |
| Pain |
0 |
0.09 |
| Refractory |
0 |
0.09 |
| Respiratory Tract |
0 |
0.09 |
| Severity Index |
0 |
0.09 |
| Thrombosis |
0 |
0.09 |
| Pain Management |
0 |
0.08 |
| Diarrhea |
0 |
0.05 |
| Headache |
0 |
0.05 |
| Patient Safety |
0 |
0.05 |
| Skin and Soft Tissue Infection |
0 |
0.05 |
| Thromboembolism |
0 |
0.05 |